Staff

QI Path Launches AI-driven Risk Intelligence Platform To Transform Risk Mitigation and Regulatory Readiness Across the Drug Development Lifecycle

BOULDER, Colo., May 27, 2025 /PRNewswire/ -- In response to the mounting regulatory, operational, and reputational pressures facing pharmaceutical companies and...

MOBILion Systems to Highlight Customer Use Cases from its MOBIE® Platform and Unveil Plans for their Next Generation Proteomics Platform at ASMS 2025

CHADDS FORD, Pa., May 27, 2025 /PRNewswire/ -- MOBILion Systems, Inc., a leader in separation science innovation, will attend and...

STORM Therapeutics Announces First Patient Dosed in Clinical Collaboration to Evaluate STC-15 in Combination with LOQTORZI® and Appointment of Atif Abbas, M.D., as Chief Medical Officer

STC-15 has demonstrated durable clinical activity and tolerability to progress into a combination study with a checkpoint inhibitor  Collaboration enables...

Futures Recovery Healthcare Announces Collaboration with Family Recovery Collective to Expand Support for Families Impacted by Addiction and Mental Health Challenges

TEQUESTA, Fla., May 27, 2025 /PRNewswire/ -- Futures Recovery Healthcare, a leading provider of comprehensive addiction and mental health treatment,...

HiberCell Announces Successful Completion of Dose Escalation and Enrollment Update for Ph1b Study Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in Advanced ccRCC

BOSTON, May 27, 2025 (GLOBE NEWSWIRE) -- HiberCell, Inc., a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis,...

error: Content is protected !!